KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - Net
Ratios

Organon (OGN) R&D In Process (2021 - 2025)

Organon has reported R&D In Process over the past 5 years, most recently at $6.0 million for Q1 2025.

  • Quarterly results put R&D In Process at $6.0 million for Q1 2025, down 60.0% from a year ago — trailing twelve months through Dec 2025 was $6.0 million (down 92.59% YoY), and the annual figure for FY2025 was $6.0 million, down 92.59%.
  • R&D In Process for Q1 2025 was $6.0 million at Organon, down from $51.0 million in the prior quarter.
  • Over the last five years, R&D In Process for OGN hit a ceiling of $97.0 million in Q2 2022 and a floor of $6.0 million in Q1 2025.
  • Median R&D In Process over the past 5 years was $15.0 million (2024), compared with a mean of $34.0 million.
  • Biggest five-year swings in R&D In Process: plummeted 60.0% in 2022 and later skyrocketed 87.5% in 2024.
  • Organon's R&D In Process stood at $79.0 million in 2021, then crashed by 87.34% to $10.0 million in 2022, then decreased by 20.0% to $8.0 million in 2023, then soared by 537.5% to $51.0 million in 2024, then plummeted by 88.24% to $6.0 million in 2025.
  • The last three reported values for R&D In Process were $6.0 million (Q1 2025), $51.0 million (Q3 2024), and $15.0 million (Q2 2024) per Business Quant data.